Pulling SEC filings + quote and writing the call…

SOPHiA GENETICS SA
Next earnings Aug 3, 2026 · consensus $-0.23 EPS, $22.1M rev
Mixed signals in the latest filings.
SOPHiA GENETICS SA shows limited reported revenue.
No income data filed.
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Sources: SEC EDGAR (CIK 0001840706, latest 144 filed 2026-06-26) · EODHD · as of 6/29/2026, 2:36:42 AM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.
Last 90 days: 0 open-market buys · 4 sales
| 2026-06-25 | Verma Abhimanyu Chief Technology Officer | Sell | 6.94K @ $5.51 | $38.2K |
| 2026-06-25 | Menu Philippe Chief Medical Officer | Sell | 5.00K @ $5.50 | $27.5K |
| 2026-06-22 | CARDOZA GEORGE Chief Financial Officer | Sell | 774.00 @ $5.38 | $4.16K |
| 2026-06-22 | Muken Ross President | Sell | 422.00 @ $5.38 | $2.27K |
| 2026-06-18 | Cox Troy Director | Award | 19.7K @ $5.46 | $108K |
| 2026-06-18 | HIBBS KATHY L Director | Award | 19.7K @ $5.46 | $108K |
| 2026-06-18 | Ossipow Vincent Director | Award | 19.7K @ $5.46 | $108K |
| 2026-06-18 | Cossery Jean-Michel Director | Award | 19.7K @ $5.46 | $108K |
1043 tracked peers · median
Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.